Endovascular Devices Headline International Stroke Conference
This article was originally published in The Gray Sheet
The American Heart Association-sponsored conference in Nashville featured late-breaking presentations of data from several major neurointerventional device trials as well as meta-analysis and pooled results confirming the benefits of endovascular intervention in several difficult-to-treat populations of stroke patients.
You may also be interested in...
Responding to a chronic care reform effort by the Senate Finance Committee, AdvaMed, device firms and several medical groups asked for demo projects and waivers to appropriately expand the use of telehealth services.
Positive data from five clinical trials and new treatment guidelines for mechanical thrombectomy devices have ushered in a new era in stroke care. In this first in a new series of podcasts, Medtech Insight spoke at the recent SNIS meeting with Brett Wall, vice president and president of the Neurovascular group at Medtronic, to find out what impact the trials and guidelines are having on stroke care, the market for mechanical thrombectomy devices, demand for Solitaire FR and the company's plans for innovation.
The October workshop will focus discussion on clinical study trial designs, patient populations, and patient selection methods, as well as study endpoints for devices targeting ischemic stroke, FDA says.